Akikusa Jonathan D, Crawford Nigel W
Rheumatology Unit, Department of General Medicine, Royal Children's Hospital (RCH), 50 Flemington Road, Parkville, 3052, Melbourne, Victoria, Australia,
Curr Rheumatol Rep. 2014 Aug;16(8):432. doi: 10.1007/s11926-014-0432-9.
As awareness of the risk of vaccine-preventable diseases for children with rheumatic diseases has increased, vaccination has become an important clinical consideration and focus of research in paediatric rheumatology. Conflicting reports in the literature and differing advice from national bodies regarding the safety of different vaccines for this patient population have led to confusion in the minds of many rheumatologists as to what is appropriate. This article will provide an overview of crucial aspects of the recently published European League Against Rheumatism recommendations regarding vaccination of paediatric patients with rheumatic disease, and will review advances in this field since their publication.
随着对患有风湿性疾病儿童的疫苗可预防疾病风险的认识不断提高，疫苗接种已成为儿科风湿病领域重要的临床考量因素和研究重点。文献中的相互矛盾的报告以及各国机构对于该患者群体使用不同疫苗安全性的不同建议，使得许多风湿病学家对于什么是合适的做法感到困惑。本文将概述最近发表的欧洲抗风湿病联盟关于风湿性疾病儿科患者疫苗接种建议的关键方面，并回顾自这些建议发表以来该领域的进展。
